FDA
-
-
-
-
-
-
-
Bausch Health completes DURECT acquisition for $63 million
-
-
-
-
-
-
-
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
-
-
-
-
-
-
-
Bausch Health Announces Third Quarter 2024 Results
-
-
-
-
-
-
-
Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
-
-
-
-
-
-
-
Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
-
-
-
-
-
-
-
Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
-
-
-
-
-
-
-
As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD)
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

